Tricyclic inhibitors of poly(ADP-ribose) polymerases
申请人:Agouron Pharmaceuticals, Inc.
公开号:US06548494B1
公开(公告)日:2003-04-15
Compounds of the formula shown below are poly(ADP-ribosyl)transferase inhibitors:
Such compounds are useful as therapeutics in treating cancers and in ameliorating the effects of stroke, head trauma, and neurodegenerative disease.